The Respiratory Society of Jiangsu Medical Association successfully held the 'China Yangtze River Medical Forum - 2021 Annual Respiratory Conference and the 27th Respiratory Academic Conference of Jiangsu Province' in Nantong from June 25 to 27, 2021. Famous experts from inside and outside the province were invited to give special academic lectures. Academic exchanges will be conducted on the diagnosis, treatment, pathogenesis, epidemiology and basic research of respiratory diseases, including COPD, bronchial asthma, lung infection, respiratory disease nursing and chronic respiratory disease management, clinical cases, and COVID-19 prevention and control.

　　The opening ceremony of the conference was presided over by Professor Song Yong from General Hospital of Eastern Theater Command of Chinese People's Liberation Army. More than 100 nationally renowned experts and scholars were invited to teach and exchange courses.  'Concept and practice', 'Respiratory clinical research status and thinking', 'Diagnosis of Pleural lymphoma', 'COPD treatment guideline recommendation and clinical practice', 'Research Progress of inhaled drugs for Chronic Airway Diseases', 'Asthma Treatment progress' and other reports. Professors from different fields gave wonderful speeches on the latest progress, guidelines, expert consensus, discipline construction, etc. The participants benefited a lot from the cutting-edge knowledge of disease diagnosis and treatment.

　　The meeting rich contents, various forms, the content including the development course of diagnosis and treatment of respiratory diseases, academic lectures, paper exchange, cases discussion, etc., comprehensively expounds the guidelines and specifications, research and progress of diagnosis and treatment of respiratory disease, new method and technology, disease rehabilitation, slow disease management and care and discipline construction, involve wide, geared to the needs of clinical and basic.

　　Chronic respiratory diseases are a series of diseases represented by chronic obstructive pulmonary disease and asthma. Among them, the prevalence of COPD in Chinese population aged 40 years and above is 14%, which is characterized by high prevalence, high disability rate, high mortality rate and high disease burden. It has a long period of disease, repeated acute exacerbation, and multiple comorbidities, which seriously affect the prognosis and quality of life of middle-aged and elderly patients.

　　By actively controlling the related risk factors, the occurrence and development of chronic respiratory diseases can be effectively prevented, and the prognosis and quality of life of patients can be significantly improved. The salt-sol therapy used by SinAShu salt-sol therapeutic instrument integrates prevention and treatment, which makes up for the shortage of prevention of respiratory diseases.

　　In the full experience of the actual efficacy of salt-sol therapy, and the limitations of the domestic salt-sol therapy room, uphold the concept of salt-sol therapy for the benefit of the people, Nanjing Kuan-cheng Technology Co., LTD. 'Xinashu salt-sol therapy instrument' project was developed and approved in 2016. In 2018, the company successfully developed the Sinashu salt-sol therapeutic instrument with completely independent intellectual property rights, and obtained the second class medical device registration certificate in 2019. The salt-sol therapeutic instrument integrated with 'medical and civil use' was officially listed in 2020.

　　Nanjing Kuan-cheng Technology Co., Ltd. participated in this academic conference with an innovative solution in the non-drug field of respiratory rehabilitation, 'Sinashu salt-sol therapeutic instrument', to listen to and learn the disciplinary progress of medical experts in the prevention, pathogenesis, diagnosis, treatment, epidemiology and basic aspects of respiratory diseases. Excellent academic presentations on new advances in clinical and basic medicine in respiratory infections, chronic obstructive pulmonary disease, interstitial lung disease, etc.

　　Salt-sol therapy can effectively dilute sputum and promote sputum excretion, dredge trachea and alleviate wheezing symptoms, and improve sleep quality. It has a positive effect on improving the pulmonary function index of patients with respiratory diseases, reducing the number of acute attacks and reducing the use of hormone drugs. This non-drug therapy has a promising application prospect and scientific research value in the field of respiratory rehabilitation.